BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025
• 2026

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 2
• 3
• 4
• 5
• 6
• 7
• 10
• 11
• 12
• 13
• 14
• 17
• 18
• 19
• 20
• 21
• 24
• 25
• 26
• 27
• 28

• Press Releases

  Rein Therapeutics Receives FDA Clearance to Resume U.S. Phase 2 Trial of LTI-03 in Idiopathic Pulmonary Fibrosis

  November 4, 2025

   · 

  4 min read
• Press Releases

  Abeona Therapeutics® Announces New Employee Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - November 3, 2025

  November 4, 2025

   · 

  3 min read
• Press Releases

  InspireMD Names Peter A. Soukas, M.D., as Chief Medical Officer

  November 4, 2025

   · 

  3 min read
• Press Releases

  Apogee Therapeutics to Participate in Upcoming Conferences

  November 4, 2025

   · 

  1 min read
• Press Releases

  Dyne Therapeutics to Present at Upcoming Investor Conferences - November 3, 2025

  November 4, 2025

   · 

  1 min read
• Press Releases

  Krystal Biotech Announces Third Quarter 2025 Financial and Operating Results

  November 4, 2025

   · 

  20 min read
• Press Releases

  ARS Pharma to Present Real-World Data on Intranasal Epinephrine at 2025 American College of Allergy, Asthma & Immunology (ACAAI) Annual Scientific Meeting

  November 4, 2025

   · 

  12 min read
• Press Releases

  Moderna Announces First Patient Dosed in Phase 1/2 Study of Investigational T-Cell Engager for Multiple Myeloma

  November 4, 2025

   · 

  4 min read
• Press Releases

  ADC Therapeutics to Host Third Quarter 2025 Financial Results Conference Call on November 10, 2025

  November 4, 2025

   · 

  5 min read
• Press Releases

  QuidelOrtho Receives FDA 510(k) Clearance for VITROS™ Immunodiagnostic Products hs Troponin I Assay

  November 4, 2025

   · 

  3 min read